WBA Quote, Financials, Valuation and Earnings

CVS Health has a net margin of -7.39% compared to Walgreens Boots Alliance's net margin of 1.88%. Walgreens Boots Alliance's return on equity of -46.98% beat CVS Health's return on equity of 7%.

Walgreens Boots Alliance has a consensus price target of $12.41, signalling upside risk potential of 8.99%. On the other hand CVS Health has an analysts' consensus of $79.49 which suggests that it could grow by 17.83%. Given that CVS Health has higher upside potential than Walgreens Boots Alliance, analysts believe CVS Health is more attractive than Walgreens Boots Alliance.

Walgreens Boots Alliance has a beta of 0.776, which suggesting that the stock is 22.379% less volatile than S&P 500. In comparison CVS Health has a beta of 0.559, suggesting its less volatile than the S&P 500 by 44.102%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 8.78%. CVS Health offers a yield of 3.94% to investors and pays a quarterly dividend of $0.67 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. CVS Health pays out 73.1% of its earnings as a dividend. CVS Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Walgreens Boots Alliance quarterly revenues are $38.6B, which are smaller than CVS Health quarterly revenues of $94.6B. Walgreens Boots Alliance's net income of -$2.9B is lower than CVS Health's net income of $1.8B. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while CVS Health's PE ratio is 16.10x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.06x versus 0.22x for CVS Health. Usually stocks with elevated PS ratios are considered overvalued.

Synergy CHC has a net margin of -7.39% compared to Walgreens Boots Alliance's net margin of --. Walgreens Boots Alliance's return on equity of -46.98% beat Synergy CHC's return on equity of --.

Walgreens Boots Alliance has a consensus price target of $12.41, signalling upside risk potential of 8.99%. On the other hand Synergy CHC has an analysts' consensus of -- which suggests that it could fall by --. Given that Walgreens Boots Alliance has higher upside potential than Synergy CHC, analysts believe Walgreens Boots Alliance is more attractive than Synergy CHC.

Walgreens Boots Alliance has a beta of 0.776, which suggesting that the stock is 22.379% less volatile than S&P 500. In comparison Synergy CHC has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 8.78%. Synergy CHC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. Synergy CHC pays out -- of its earnings as a dividend.

Walgreens Boots Alliance quarterly revenues are $38.6B, which are larger than Synergy CHC quarterly revenues of --. Walgreens Boots Alliance's net income of -$2.9B is higher than Synergy CHC's net income of --. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while Synergy CHC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.06x versus -- for Synergy CHC. Usually stocks with elevated PS ratios are considered overvalued.

SunLink Health Systems has a net margin of -7.39% compared to Walgreens Boots Alliance's net margin of -9.16%. Walgreens Boots Alliance's return on equity of -46.98% beat SunLink Health Systems's return on equity of 12.24%.

Walgreens Boots Alliance has a consensus price target of $12.41, signalling upside risk potential of 8.99%. On the other hand SunLink Health Systems has an analysts' consensus of -- which suggests that it could fall by --. Given that Walgreens Boots Alliance has higher upside potential than SunLink Health Systems, analysts believe Walgreens Boots Alliance is more attractive than SunLink Health Systems.

Walgreens Boots Alliance has a beta of 0.776, which suggesting that the stock is 22.379% less volatile than S&P 500. In comparison SunLink Health Systems has a beta of 1.124, suggesting its more volatile than the S&P 500 by 12.415%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 8.78%. SunLink Health Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. SunLink Health Systems pays out -- of its earnings as a dividend.

Walgreens Boots Alliance quarterly revenues are $38.6B, which are larger than SunLink Health Systems quarterly revenues of $7.3M. Walgreens Boots Alliance's net income of -$2.9B is lower than SunLink Health Systems's net income of -$671K. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while SunLink Health Systems's PE ratio is 4.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.06x versus 0.22x for SunLink Health Systems. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of -7.39% compared to Walgreens Boots Alliance's net margin of 5.74%. Walgreens Boots Alliance's return on equity of -46.98% beat UnitedHealth Group's return on equity of 21.74%.

Walgreens Boots Alliance has a consensus price target of $12.41, signalling upside risk potential of 8.99%. On the other hand UnitedHealth Group has an analysts' consensus of $385.34 which suggests that it could grow by 22.9%. Given that UnitedHealth Group has higher upside potential than Walgreens Boots Alliance, analysts believe UnitedHealth Group is more attractive than Walgreens Boots Alliance.

Walgreens Boots Alliance has a beta of 0.776, which suggesting that the stock is 22.379% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.442, suggesting its less volatile than the S&P 500 by 55.841%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 8.78%. UnitedHealth Group offers a yield of 2.68% to investors and pays a quarterly dividend of $2.21 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Walgreens Boots Alliance quarterly revenues are $38.6B, which are smaller than UnitedHealth Group quarterly revenues of $109.6B. Walgreens Boots Alliance's net income of -$2.9B is lower than UnitedHealth Group's net income of $6.3B. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while UnitedHealth Group's PE ratio is 13.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.06x versus 0.71x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.